Regulatory Post-Marketing Surveillance Study for Brolucizumab

Clinical trial NCT04985487 · RECRUITING

Trial details

NCT number: NCT04985487
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration

Start date: 2021-08-18
Primary completion: 2026-06-14
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.